Galactokinase Deficiency

What Is It, Causes, and More

Author: Corinne Tarantino, MPH

Editors: Alyssa Haag, Józia McGowan, DO

Illustrator: Jillian Dunbar

Copyeditor: Joy Mapes

What is galactokinase deficiency?

Galactokinase deficiency is a rare deficiency of galactokinase, an enzyme that helps break down galactose. Galactose is a simple sugar that is most often in foods containing lactose (e.g., milk, cheese, yogurt). When galactose is eaten, galactokinase speeds up the conversion of galactose to galactose-1-phosphate, which is the first step in producing energy from galactose. Galactose or galactitol, a reduced form of galactose made when there is no other way to remove galactose, may build up in the body if there is a deficiency of galactokinase. 

Galactokinase deficiency is a type of galactosemia, a group of inherited disorders passed down from parents to children that cause increased galactose in the blood. The most common galactosemia is classic galactosemia, a deficiency of galactose-1-phosphate uridyltransferase (GALT) that can cause severe complications, including liver failure and neonatal death.

What causes galactokinase deficiency?

Galactokinase deficiency is caused by a mutation in the GALK1 gene, one of the major genes involved in making galactokinase. This mutation is passed down from parents to their children in an autosomal recessive manner, which means that a child must receive two copies of the mutated gene in order to have the deficiency.

Excited Mo character in scrubs
Join millions of students and clinicians who learn by Osmosis!
Start Your Free Trial

What are the signs and symptoms of galactokinase deficiency?

Infants and children with galactokinase deficiency commonly develop cataracts of both eyes. Cataracts are characterized by clouding of the lens, the clear structure located at the front of the eye. With galactokinase deficiency, there is an accumulation of galactitol in the lens of the eye. This buildup of galactitol can increase the pressure of the eye, which can cause swelling and, ultimately, cataracts. Signs that an infant has cataracts include difficulty following objects with their eyes and not smiling in response when someone smiles at them. 

A child with galactokinase deficiency may also develop a pseudotumor cerebri, which is characterized by pressure around the brain that mimics symptoms of a large brain tumor (e.g., changes to vision, nausea, ringing in the ears). The increased pressure typically results from galactitol buildup in the cerebrospinal fluid (CSF) surrounding the brain and spinal cord.

Symptoms may begin as soon as an infant begins breastfeeding due to the lactose present in breastmilk. Additional, less common symptoms include lack of coordination, cognitive impairment, deafness, a small head, small gonads (i.e., testicles, ovaries), and slow growth in height and weight. 

How is galactokinase deficiency diagnosed?

Galactokinase deficiency is diagnosed by a medical evaluation, including assessment of the individual’s signs and symptoms and review of their medical history, followed by a thorough physical examination. Laboratory blood and urine tests can check for high levels of galactose in the individual’s blood and urine. Sometimes, a newborn screening will reveal an increase of galactose in the newborn’s blood, which may indicate a galactokinase deficiency. If initial tests indicate high galactose levels, additional blood tests may be recommended to investigate the levels of galactokinase in the blood and possibly assess for alterations to the sequence of the GALK1 gene.

Individuals who have cataracts typically need a detailed eye examination by a general clinician or ophthalmologist, a clinician who specializes in disorders of the eyes. Moreover, most individuals with pseudotumor cerebri will require imaging of the brain, such as computerized tomography (CT) scans or magnetic resonance imaging (MRI), to confirm diagnosis. A lumbar puncture, a procedure in which a clinician uses a hollow needle to remove CSF from the lower back and measure the pressure in the CSF, can also confirm a diagnosis of pseudotumor cerebri.

How is galactokinase deficiency treated?

Galactokinase deficiency is treated with a lactose- and galactose-restricted diet -- which requires limiting foods such as cheese, butter, and chocolate -- and calcium supplementation. Typically, cataracts that are due to galactokinase deficiency resolve after the individual makes these dietary changes. The individual or their guardians may consult a nutritionist for help navigating the new diet. Sometimes, parents may consult a genetic counselor to discuss the likelihood of other family members inheriting the disease.

What are the most important facts to know about galactokinase deficiency?

Galactokinase deficiency, a form of galactosemia, is a genetic condition that results in the buildup of galactose in the body. Galactokinase deficiency is usually caused by a mutation in the GALK1 gene. Cataracts or pseudotumor cerebri can be symptoms for an infant with galactokinase deficiency. The condition is often diagnosed through a medical evaluation and blood tests. Treatment usually consists of a lactose- and galactose-restricted diet with calcium supplementation.

Quiz yourself on Galactokinase Deficiency

11 Questions available

Quiz now!

Watch related videos:

Mo with coat and stethoscope

Want to Join Osmosis?

Join millions of students and clinicians who learn by Osmosis!

Start Your Free Trial

Related links

Disorders of Carbohydrate Metabolism: Pathology Review
Eye conditions: Refractive Errors, Lens Disorders and Glaucoma: Pathology Review

Resources for research and reference

Berry, G. T. (2021, March 11). Classic galactosemia and clinical variant galactosemia. In GeneReviews [Internet]. Retrieved from 

Bidot, S., Saindane, A. M., Peragallo, J. H., Bruce, B. B., Newman, N. J., & Biousse, V. (2015). Brain imaging in idiopathic intracranial hypertension. Journal of Neuro-Ophthalmology: The Official Journal of the North American Neuro-Ophthalmology Society, 35(4): 400-411. DOI: 10.1097/WNO.0000000000000303

Kalaydjieva, L., Perez-Lezaun, A., Angelicheva, D., Onengut, S., Dye, D., Bosshard, N. U., Jordanova, A., Savov, A., Yanakiev, P., Kremensky, I., Radeva, B., Hallmayer, J., Markov, A., Nedkova, V., Tournev, I., Aneva, L., & Gitzelmann, R. (1999). A founder mutation in the GK1 gene is responsible for galactokinase deficiency in Roma (Gypsies). American Journal of Human Genetics, 65(5): 1299–1307. DOI: 10.1086/302611

Kishnani, P. S., & Chen, Y. (2018). Glycogen storage diseases and other inherited disorders of carbohydrate metabolism. In J. L. Jameson, A. Fauci, D. Kasper, S. Hauser, D. Longo, & J. Loscalzo (Eds.), Harrison's principles of internal medicine (20th ed.). McGraw-Hill. 

National Center for Advancing Translational Sciences (NCATS). (2021, February 1). Galactokinase deficiency. In Genetic and Rare Diseases Information Center (GARD): Diseases. Retrieved from 

National Organization for Rare Disorders (NORD), Zupan, M., & Berry, G. T. (2019). Galactosemia. In Rare disease database. Retrieved from

Ramani, P. K., Arya, K. (2021, January 11). Galactokinase deficiency. In StatPearls [Internet]. Retrieved from   

Rubio-Gozalbo, M. E., Derks, B., Das, A. M., Meyer, U., Möslinger, D., Couce, M. L., Empain, A., Ficicioglu, C., Palacios, J. N., De Los Santos De Pelegrin, M. M., Rivera, I. A., Scholl-Bürgi, S., Bosch, A. M., Cassiman, D., Demirbas, D., Gautschi, M., Knerr, I., Labrune, P., Skouma, A., Verloo, P., Wortmann, S. B., Treacy, E. P., Timson, D. J., & Berry, G. T. (2021) Galactokinase deficiency: Lessons from the GalNet registry. Genetics in Medicine, 23(1): 202-210. DOI: 10.1038/s41436-020-00942-9 

Thomas, J. A., Van Hove, J. L. K., Larson, A. A., & Baker, P. R., II. (2020). Inborn errors of metabolism. In W. Hay, Jr., M. Levin, M. Abzug, & M. Bunik (Eds.), Current diagnosis & treatment: Pediatrics (25th ed.). McGraw-Hill.